Navigation Links
MRI better than MDCT in detecting endoleaks, study says
Date:4/11/2008

Contrast-enhanced MR imaging is significantly superior to 16 slice multidetector CT in the detection of endoleaks after endovascular repair of abdominal aortic aneurisms (EVAR), according to a recent study conducted by researchers at Ospedale San Giovanni in Bellinzona, Switzerland.

Endovascular repair of abdominal aortic aneurysms has become a viable alternative treatment to open surgery for many patients. Endoleak development represents a complication of endovascular aortic aneurysm repair and is characterized by blood flow outside the stent-graft lumen but within the aneurysm sac, said Rolf Wyttenbach, MD, lead author of the study. Patients after EVAR need livelong imaging surveillance to detect endoleaks. CT is most commonly used for imaging follow-up of these patients. , A few prior studies suggested that MRI may be superior to CT for the detection of endoleaks. However, these studies mostly used single or 4-row MDCT and standard gadolinium contrast media for MR imaging, he said.

The study consisted of 43 patients who had undergone EVAR. Each of the patients had both MDCT and MRI within one week of the procedure. According to the study, MRI was performed using a high relaxivity contrast medium and for MDCT, an iodine containing agent was used. Upon the completion of the study, two observers evaluated MRI and MDCT separately.

The study showed that 21 endoleaks were detected in 18 patients. Sensitivity, specificity and accuracy for endoleak detection were 100%, 96% and 98% for reader 1 and 90%, 81% and 85% for reader 2 on MRI and 48%, 96% and 74% for both readers on MDCT.

The results indicate that MR is a good choice for diagnosing endoleaks. In addition, MRI does not expose the patients to radiation and the MR contrast agent is less nephrotoxic in the clinically used dose compared to iodinated contrast agents used for CT. For this reason MRI may become a preferred imaging modality to follow-up patients after end
'/>"/>

Contact: Necoya Tyson
necoya@arrs.org
703-858-4304
American Roentgen Ray Society
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Boston College biologists build a better mouse model for cancer research
2. Two Liver Cancer Treatments Better Than One
3. Know Your Personal Genetic Health to Age Better Now!
4. AAPPO Releases Diabetes Toolkit to Spur Action on Better Diabetes Care
5. Better care for dementia patients through new funding
6. Better-Educated Smokers More Likely to Quit After Seeing Ads
7. AMICAS and RIA Partner for Better Customer Service in Radiology
8. Medicare Advantage Plans Have New, Better Way to Access CMS Data
9. Genomic Profiling of Breast Cancers a Better Treatment Tool
10. Two Drugs Better Than One for High Blood Pressure
11. New Drugs No Better Than Older Ones for Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... up to 50 percent savings on medical services and ...lleville, Ill. (Vocus) October 6, 2008 -- Allsup a...sup.com/Health-Discount-Program.aspx/?=PRJ2 [Healt...am] to help millions of people with disabilities g...rvices. The program is among the new financial and...
(Date:10/5/2008)...rug samples distributed to children may be unsafe,... Health Alliance and Hasbro Children,s Hospital. T...sample use among children, appears in the October ...also serve as researchers at Harvard Medical Schoo...iversity, found that children commonly receive fre...
(Date:10/5/2008)... a long way toward helping severely obese individu...ortant daily tasks, according to researchers at th...am assessment where patients reported, on average,...uals who were more active reported better overall-...n their ability to perform daily tasks as measured...
(Date:10/3/2008)...ities Named In Wash. Lawsuit, SEATTLE, Oct. 3 /PR...dditional allegations in the class action lawsuit ...ts 16 facilities in the state of Washington [see,l...e #2:08-cv-01332-JCC) in,United States District Co...e original complaint (Case #08-2-28645-2KNT), file...
Breaking Medicine News(10 mins):Health News:Allsup Introduces Health Discount Program to Millions of People with Disabilities 2Health News:Allsup Introduces Health Discount Program to Millions of People with Disabilities 3Health News:Free drug samples carry risks for children 2Health News:A little exercise goes a long way for severely obese 2Health News:Additional Allegations Filed Against Elder Care Operator 2Health News:Additional Allegations Filed Against Elder Care Operator 3Health News:Additional Allegations Filed Against Elder Care Operator 4Health News:Additional Allegations Filed Against Elder Care Operator 5
...lication that affects up to 25 percent of lung tra...s// a significant risk factor for later deadly bro...rch appears in the first issue for March 2007 of t...d Critical Care Medicine, published by the America...
... employees to order prescription drugs through the...y think they are//. In recent years, mail-order p...s), have become popular among cost-conscious compa... their employees. Their belief – supported by a 20...
...tists to create part-animal and part-human only fo...ses//. This was announced by the health minister C... on fertility treatment and embryo research. Perm... scientists who are desirous of creating cybrid em...
... come out with a cheap and effective drug for mala...tion with the Drugs// for Neglected Diseases initi...ncy Medecins Sans Frontieres (MSF). This treatment...sunate and amodiaquine. The earlier treatment for...
Other Medicine News:Health News:Primary Graft Dysfunction Is Risk Factor For Lung Transplant Problem 2Health News:Mail-Order Drugs: Deal or No Deal? 2
(Date:10/3/2008)... is the newest study site, PHILADELPHIA, Oct. 3 /...of Philadelphia today received a contract to manag...y. Children,s Hospital will manage local,participa...n County, New,Jersey. The study is funded by the N...cipate approximately 1,000 families in Burlington,...
(Date:10/2/2008)...ults of Rosetta Genomics, microRNA-based,Test, miR...rom non Squamous non Small Cell Lung Cancer, ...he miRview(TM) Technology First Approved for Clini...lexity Molecular Pathology Lab ...ecting to Launch miRview(TM) Squamous Later This ...
(Date:10/2/2008)...re-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AE... focused on,endocrine therapy and oncology, today ...atient recruitment for its Phase 2 trial in ovaria...asing hormone (LHRH) agonist,linked to doxorubicin...t,recruitment was taken following recent first sta...
(Date:10/1/2008)...e sublingual lozenge) developed to be the first s... night when patients awaken and have diffi...ct. 1 /- Transcept Pharmaceuticals,I...pany, announced today,that it has submitted a New ...dministration (FDA) for its lead product candidate...
Breaking Medicine Technology:The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 3Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 4Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 6Majority of 2 4 Million U S Children With ADHD Not Diagnosed or Consistently Treated According to New Gold Standard Study by Cincinnati Childrens Re 389 1Majority of 2 4 Million U S Children With ADHD Not Diagnosed or Consistently Treated According to New Gold Standard Study by Cincinnati Childrens Re 389 2Majority of 2 4 Million U S Children With ADHD Not Diagnosed or Consistently Treated According to New Gold Standard Study by Cincinnati Childrens Re 389 3Majority of 2 4 Million U S Children With ADHD Not Diagnosed or Consistently Treated According to New Gold Standard Study by Cincinnati Childrens Re 389 4Teens who see more smoking in movies may have increased risk of becoming established smokers 384 1Teens who see more smoking in movies may have increased risk of becoming established smokers 384 29 25 of U S Kids Have ADHD 379 19 25 of U S Kids Have ADHD 379 29 25 of U S Kids Have ADHD 379 3Work Time Predicts Sleep Time 375 1Work Time Predicts Sleep Time 375 2
...Call/ -- CEL-SCI,CORPORATION announces that CEL-10...influenza antigen in combination with MAS-1, a,wat... were,presented on May 23, 2007 by Dr. Daniel Zimm... Immunology at CEL-SCI at the,American Society of ...ronto, Canada. , This new finding with CEL-1000 ma...
...e on Work Status and,Productivity, WASHINGTON, May...nted today at Digestive Disease Week(R) 2007 (DDW)...ive Ulcerative Colitis 1,& 2) show that subjec...olitis (UC) who had responded to REMICADE(R),(infl...ned,improvement in their clinical symptoms for up ...
Other Medicine Technology:CEL-SCI'S CEL-1000 Shown to Significantly Enhance Immune Response,Against Avian Flu Antigen in Animals 2Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 2Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 3Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 4Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 5Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 6Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 7Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 8Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 9
OCD-3000 pnuematic conserving regulator for large cylinder.
OCD-3000 pnuematic conserving regulator.
...ing an oxygen conserver, it's important to have a ...lied, a name synonymous with innovative excellence...ade; and Mini Liberty™, two totally automati...AA battery, the Mini Liberty can be used 8 hours a...
OCD-2000 electronic conserving regulator.
Medicine Products: